REGN34:BVMF
Regeneron Pharmaceuticals Inc BDR
R$67.62
arrow_downward
-0.41%(-0.28) 1D
Okt 16, 4:56:00 PM GMT-3 · BRL
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa REGN34...
Buksan
R$67.62
Mataas
R$67.62
Mababa
R$67.62
Mkt. cap
81.41B
Avg. na dami
766.00
Dami
17.00
Mataas nang 52-wk
R$73.13
Mababa nang 52-wk
R$49.91
Mga natitirang share
101.14M
Bilang ng mga empleyado
15K
Buksan
R$67.62
Mataas
R$67.62
Mababa
R$67.62
Mkt. cap
81.41B
Avg. na dami
766.00
Dami
17.00
Mataas nang 52-wk
R$73.13
Mababa nang 52-wk
R$49.91
Mga natitirang share
101.14M
Bilang ng mga empleyado
15K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
ad-hoc-news.de
·
7 oras ang nakalipas
UBS lifts Regeneron stock target to USD 978.00
Financial-News.co.uk
·
9 oras ang nakalipas
CHMP backs wider dosing gap for Regeneron’s Libtayo
Stock Titan
·
10 oras ang nakalipas
EU advisers recommend a 15-minute option for some cancer infusions after a tolerated first dose
ad-hoc-news.de
·
15 oras ang nakalipas
Regeneron stock pre-market at EUR 710.60
Profile
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
Tungkol sa Regeneron Pharmaceuticals Inc BDR
CEOLeonard Schleifer
Mga Empleyado15.3K
Itinatag1988
HeadquartersTarrytown, New York, Estados Unidos
Sektor-
Websiteregeneron.com